TKT and leukemia: Moreover, we were able to show a genetic model with BV173 cells stably expressing both luciferase and HSV-TK for the chemotherapy-free selective ablation of transduced leukemic cells upon treatment with GCV, demonstrating that the cardiac impairment at late stages of ALL progression could not be reverted by the remission of leukemia [25].